Skip to content
Willingsford Healthcare
  • About
    • Management
    • Research & Development
    • Quality Assured
    • Sustainability
    • News
    • Contact
  • Technology
    • MPPT Wound Healing
    • Comparative Clinical Study of MPPT, Antibiotic and Antiseptic
    • Clinical evaluation on 9 dehisced surgical wounds and 1 category 4 pressure ulcer
    • MPPT treatment of wounds and pressure ulcers in spinal cord injured patients
    • MPPT induces tissue regeneration, whereas PHMB causes degeneration, in patient
    • Clinical evaluation in pyoderma gangrenosum
    • Preclinical study
    • Case reports – humans
    • Case reports – veterinary
    • Health Economics
    • AMR – Antimicrobial Resistance
    • Pollution – Plastics, Antimicrobials, Chemicals
    • The Microbiome and the Wound
  • Wounds
    • Acapsil and Amicapsil – Treatment for wounds in humans
      • Boils, furuncles, carbuncles and abscesses
      • Dehisced surgical wounds
      • Diabetic foot ulcers
      • Pressure ulcers
      • Trauma wounds
      • Venous leg ulcers
    • SertaSil – Treatment for wounds in animals
  • Dermatology
    • Aprobaxil – Treatment for wounds associated with dermatological conditions in humans
      • Acne
      • Atopic dermatitis – and eczema (AD)
      • Boils, furuncles, carbuncles and abscesses
      • Hidradenitis Suppurativa
      • Psoriasis
      • Pyoderma gangrenosum
    • Adinasil – Treatment for wounds associated with dermatological conditions in animals
  • Local
    • DK
    • ES
    • UK and rest-EU
  • FAQ
  • Shop
Menu

Micropore Particle Technology for wound healing

Contact Us for more information
E-mail
Copyright 2019 - Willingsford Limited (No 7462271) registered in England and Wales.
Close Menu
Close Panel

By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Accept